Trial Profile
A PROSPECTIVE EVALUATION OF THE RADIOGRAPHIC EFFICACY OF ETANERCEPT IN PATIENTS WITH RHEUMATOID ARTHRITIS OR PSORIATIC ARTHRITIS
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Etanercept (Primary)
- Indications Psoriatic arthritis; Rheumatoid arthritis
- Focus Therapeutic Use
- Acronyms PRERA
- Sponsors Pfizer
- 24 May 2018 Status changed from recruiting to completed.
- 12 Dec 2017 Planned End Date changed from 1 Apr 2018 to 28 Apr 2018.
- 12 Dec 2017 Planned primary completion date changed from 1 Apr 2018 to 28 Apr 2018.